RNAi & miRNA

Training Courses

Keynote Speakers

Reuven Agami
Head of Division / Group Leader, The Netherlands Cancer Institute

Gunter Meister
Professor, University of Regensburg

Overview

Welcome to the RNAi & miRNA track of the Genomics Research conference and exhibition. This year's event will be held in Boston.

This conference will detail the cutting edge research taking place in the two fields with a particular emphasis on the complex roles microRNA play in cancer and their regulation. The latest developments in both therapeutics and delivery of RNAi based medicines will also be discussed to help map out the commercial trends occurring in this field. Other conference tracks at this event include Advances in qPCR, Epigenetics, Next-Gen Sequencing, and Genomic Biomarkers

Other conference tracks at this event include Advances in qPCR, Epigenetics, Next-Gen Sequencing, and Genomic Biomarkers. Registered delegates will have access to all eight meetings ensuring a very cost-effective trip.

In addition the event will also host a cutting edge training course which can be viewed here and two business tutorials which can be viewed here.

Agenda Topics

Delivery Techniques
miRNA Biology
miRNAs in Cancer
RNAi and miRNA Therapeutics

Sponsorship and Exhibition Opportunities

Exhibition Team,
exhibitors@selectbio.com
+44 (0) 1206 501654

Distinguished Faculty

Aurora Esquela Kerscher, Assistant Professor, Eastern Virginia Medical School
Michael McManus, Assistant Professor, University of California San Francisco
Anthony Leung, Assistant Professor, Johns Hopkins Bloomberg School of Public Health
Anja Hoeg, Associate Director of Discovery, Santaris Pharma
Karen Bulock, Associate Director/Vice President, RXi Pharmaceuticals
Alexander Pertsemlidis, Associate Professor, The University of Texas Health Science Center at San Antonio
Bhavneet Bhinder, Bioinformatics Engineer, Memorial Sloan Kettering Cancer Center
Xianbin Yang, Director, AM Biotechnologies LLC
Sven Diederichs, Group Leader, University Of Heidelberg
Dan Peer, Head, Tel Aviv University
Anthony Saleh, IRTA scientist, NIDCD/NIH
Enal Razvi, Managing Director, Select Biosciences Inc
Christopher Cheng, Postdoctoral Fellow, Yale University
Alex Chenchik, President/CSO, Cellecta Inc
Kan Ding, Professor, The National Center for Drug Screening
Andrew Miller, Professor, Kings College London
Scott Eliasof, Vice President, Cerulean Pharma Inc
Peter Mouritzen, Vice President, Exiqon A/S
Mark Behlke, Vice President/Chief Scientific Officer, Integrated DNA Technologies Inc

Corporate Sponsors	Web Sponsors	Offical Journal Partner	Networking